AVOCENT CORP·4

Feb 3, 6:01 PM ET

DAMBRACKAS WILLIAM A 4

4 · AVOCENT CORP · Filed Feb 3, 2005

Insider Transaction Report

Form 4
Period: 2005-02-01
DAMBRACKAS WILLIAM A
Exec VP, Advanced Technology
Transactions
  • Purchase

    Common Stock

    2005-02-01$25.36/sh+54$1,3692,777 total
  • Purchase

    Common Stock

    2005-02-01$22.95/sh+725$16,6392,723 total
Holdings
  • Options (rights to buy)

    Exercise: $40.98From: 2004-02-05Exp: 2014-02-05Common Stock (20,000 underlying)
    20,000
  • Options (rights to buy)

    Exercise: $27.25From: 2003-03-07Exp: 2013-03-07Common Stock (18,000 underlying)
    18,000
  • Options (rights to buy)

    Exercise: $28.96From: 2004-08-19Exp: 2014-08-19Common Stock (10,000 underlying)
    10,000
  • Options (rights to buy)

    Exercise: $21.77From: 2002-04-15Exp: 2012-04-15Common Stock (3,000 underlying)
    3,000
  • Options (rights to buy)

    Exercise: $29.31From: 2001-01-03Exp: 2011-01-03Common Stock (6,000 underlying)
    6,000
Footnotes (3)
  • [F1]Grant date, 15% vests every six months for the first 12 months, 6.25% vests quarterly for the following 24 months and 5% vests quarterly for the remaining 12 months.
  • [F2]Grant date, 25% vests after 6 months and in 10 equal quarterly installments thereafter.
  • [F3]Shares purchased under the Avocent Corporation employee stock purchase plan.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -